Nantong Neiwa Faith Pharmaceutical Co., Ltd. was established in October 2020 and is a limited liability company with a registered capital of 30 million yuan. It is a specialized pharmaceutical enterprise integrating registration, production, and sales. The core management team of the company consists of outstanding personnel who have been deeply involved in the pharmaceutical industry for more than ten years. The sales network covers the entire country, including 300 tertiary Grade-A hospitals and more than 500 secondary hospitals. Nanjing Ninghe Hengxin Pharmaceutical Co., Ltd. was established in August 2020 as a drug research and development center, focusing on drug development and technological innovation, covering the entire process of project initiation, process development, formulation screening, and product registration.
The company places great importance on full lifecycle quality management and compliance operations. It has established a specialized quality control team and built a complete quality control standard and full-process supervision system, making it a modern pharmaceutical enterprise fully meeting domestic GMP production conditions and management requirements. The company mainly engages in the domestic repackaging of drugs produced overseas. Currently, it cooperates with Meiji Seika Pharma Co., Ltd. in Japan, repackaging and selling its products, which are new third-generation oral cephalosporin formulations, including cefditoren pivoxil tablets and cefditoren pivoxil granules, with an annual production capacity of 1 billion RMB.
At the same time, relying on a dedicated registration affairs department, the company deeply researches industry regulations and policies, strictly follows industry regulatory requirements, national standards, and relevant management systems, and coordinates the registration application, data filing, and change management of products.